DEMONSTRATION OF 2 GROUP-SPECIFIC TSTAS IN ADENOVIRUS-INDUCED TUMORS

[1] CROSS-REACTING TSTAS IN ADENO-7 AND ADENO-12 TUMORS DEMONSTRATED BY 51CR-CYTOTOXICITY AND ISOGRAFT REJECTION TESTS [J]. INTERNATIONAL JOURNAL OF CANCER, 1969, 4 (03) : 279 - &

[2] ANKERST J, IN PRESS

[3] ON NATURE OF TRANSPLANTATION IMMUNITY IN ADENOVIRUS TUMOR SYSTEM [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 125 (06) : 983 - &

[4] BERMAN LD, 1967, J NATL CANCER I, V39, P847

[5] EDDY BE, 1964, P SOC EXP BIOL MED, V117, P575, DOI 10.3181/00379727-117-29642

[6] TRANSFORMATION OF PRIMARY RAT EMBRYO CELLS BY ADENOVIRUS TYPE2 [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1967, 58 (03) : 1205 - +

[7] MECHANISM OF VIRAL CARCINOGENESIS BY DNA MAMMALIAN VIRUSES .2. VIRAL-SPECIFIC RNA IN TUMOR CELLS INDUCED BY WEAKLY ONCOGENIC HUMAN ADENOVIRUSES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1967, 57 (03) : 806 - &

[8] GOLDNER H, 1964, P SOC EXP BIOL MED, V117, P851

[9] GREEN M, 1969, CANADA CANCER C, V8, P261

[10] Habel K, 1967, Curr Top Microbiol Immunol, V41, P85

[1] CROSS-REACTING TSTAS IN ADENO-7 AND ADENO-12 TUMORS DEMONSTRATED BY 51CR-CYTOTOXICITY AND ISOGRAFT REJECTION TESTS [J]. INTERNATIONAL JOURNAL OF CANCER, 1969, 4 (03) : 279 - &

[2] ANKERST J, IN PRESS

[3] ON NATURE OF TRANSPLANTATION IMMUNITY IN ADENOVIRUS TUMOR SYSTEM [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 125 (06) : 983 - &

[4] BERMAN LD, 1967, J NATL CANCER I, V39, P847

[5] EDDY BE, 1964, P SOC EXP BIOL MED, V117, P575, DOI 10.3181/00379727-117-29642

[6] TRANSFORMATION OF PRIMARY RAT EMBRYO CELLS BY ADENOVIRUS TYPE2 [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1967, 58 (03) : 1205 - +

[7] MECHANISM OF VIRAL CARCINOGENESIS BY DNA MAMMALIAN VIRUSES .2. VIRAL-SPECIFIC RNA IN TUMOR CELLS INDUCED BY WEAKLY ONCOGENIC HUMAN ADENOVIRUSES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1967, 57 (03) : 806 - &

[8] GOLDNER H, 1964, P SOC EXP BIOL MED, V117, P851

[9] GREEN M, 1969, CANADA CANCER C, V8, P261

[10] Habel K, 1967, Curr Top Microbiol Immunol, V41, P85